SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

May 25, 2015 at 15:20 | Source: Moneycontrol.com
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to media report in Financial Express on May 22, 2015 titled
May 22, 2015 at 14:28 | Source: Moneycontrol.com
Sequent Scientific Ltd has informed BSE that in respect of the QIP, the QIP Committee of the Company at its meeting held on May 22, 2015, has approved the closure of the QIP on May 22, 2015.
May 22, 2015 at 13:22 | Source: Moneycontrol.com
Strides Arcolab Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2015, has recommended dividend at 30 percent viz., Rs. 3/- per share for the year ended March 31, 2015 and the dividend payout date will be on or before August 30, 2014
May 22, 2015 at 12:43 | Source: Moneycontrol.com
With reference to the earlier letter dated May 09, 2015 about the nomination of Mr. Bradley Simpson by Merck KGaA, Merck Ltd has informed BSE that Mr. Bradley Simpson has been appointed as the Non-Executive Director of the Company w.e.f. May 21, 2015.
May 21, 2015 at 18:47 | Source: Moneycontrol.com
Angel Broking has maintained a neutral rating on GlaxoSmithKline Pharmaceuticals, in its May 21, 2015 research report.
May 21, 2015 at 15:42 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, to consider and approve the Audited Financial Result of the Company for the year ended March 31, 2015.
May 21, 2015 at 14:54 | Source: Moneycontrol.com
TTK Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2015, inter alia, has recommended a Dividend of Rs.4.50/- per Equity Share of Rs.10/- each (45 percent), for the financial year ended March 31, 2015 which shall be paid on the 21st day from the conclusion of the Annual General Meeting.
May 21, 2015 at 13:51 | Source: Moneycontrol.com
Proto Developers & Technologies Ltd has informed BSE that, pursuant to Section 161(1) of the Companies Act, 2013 the Board of Directors in their meeting held on May 14, 2015, has appointed Mrs. RAJNI SHARMA as Additional director of the company with immediate effect to hold the office till the conclusion of next Annual General Meeting.
May 21, 2015 at 13:33 | Source: Moneycontrol.com
Fulford India Ltd has informed BSE that Mr. Kevin Ali, a non-executive, non-independent director has resigned from the Board of Directors of the Company with effect from January 02, 2015.
May 21, 2015 at 12:25 | Source: Moneycontrol.com
Dil Ltd has informed BSE that a meeting of the Audit Committee & Board of Directors of the Company will be held on May 29, 2015, to consider and approve Audited financial statements (Standalone and Consolidated) for the financial year ended March 31, 2015 and recommend final equity dividend, if any, for the financial year 2014-2015.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

12.06 PM May 16th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

12.18 PM Apr 17th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

3.55 PM Mar 26th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

2.00 PM Mar 25th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

4.39 PM Mar 13th 2014

vk1939

Platinum Member

171 Followers

GlaxoSmithKline  

7.08 PM Feb 18th 2014

yrfriend007

Platinum Member

133 Followers

GlaxoSmithKline  

3.51 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

2.00 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

7810 Followers

GlaxoSmithKline  

1.51 PM Feb 18th 2014

kabiroberoi
90

New Member

0 Follower

GlaxoSmithKline  

1.04 PM Feb 18th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.